98324183 - ESPEROVAX

Information

• Trademark
• 98324183

• Source

• Serial Number

  98324183

• International Classifications

  • 5 - Pharmaceutical and veterinary preparations
  • 42 - Scientific and technological services and research and design relating thereto

• Filing Date

  December 20, 2023
  a year ago

• Transaction Date

  January 07, 2025
  3 months ago

• Status Date

  January 07, 2025
  3 months ago

• Published for Opposition Date

  November 26, 2024
  5 months ago

• Location Date

  January 07, 2025
  3 months ago

• Status Code

  688

• Current Location

  INTENT TO USE SECTION

  Employee Name

  LEE, CATHERINE

• Attorney Docket Number

  61930-US-NF2

  Attorney Name

  J. Matthew Buchanan

  Law Office Assigned Location Code

  M10

• Owners

  • Esperovax, Inc.

Case File Statements

• GS0051: Vaccines; Oral vaccines; Modified cells for medical or clinical use; yeast-based pharmaceuticals for prevention or treatment of infectious diseases; Oral vaccine preparations; Pharmaceutical products for the treatment of infectious diseases; Recombinant yeast-based pharmaceutical products for prevention or treatment of infectious diseases; Yeast-based oral vaccines; Pharmaceutical preparations, namely, a drug delivery system for oral administration of vaccines comprising yeast-based oral vaccines; Pharmaceutical products, namely, yeast-based oral vaccines; Biological and pharmaceutical preparations, namely, recombinant yeast for prevention or treatment of infectious diseases
• GS0421: Medical research in the field of vaccines and medicines; Research and development of vaccines and medicines; Research and development in the pharmaceutical and biotechnology fields; Scientific research in the field of vaccines and medicines; Pharmaceutical research and development; Research and development in the field of immunology; Research and development in the field of microorganisms, namely, research and development related to yeast; Research and development in the field of therapeutics; Development of pharmaceutical preparations and medicines; Scientific study and research in the field of medicine; Scientific study and research in the field of healthcare products; Medical and scientific research; Research and development of pharmaceutical and therapeutic preparations; Pharmaceutical, biologic, and vaccine research and development

Case File Event Statements

• 12/20/2023 - a year ago

  1 - NEW APPLICATION ENTERED Type: NWAP

• 4/1/2024 - a year ago

  2 - NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Type: NWOS

• 7/22/2024 - 9 months ago

  3 - ASSIGNED TO EXAMINER Type: DOCK

• 7/23/2024 - 9 months ago

  4 - NON-FINAL ACTION WRITTEN Type: CNRT

• 7/23/2024 - 9 months ago

  6 - NOTIFICATION OF NON-FINAL ACTION E-MAILED Type: GNRN

• 7/23/2024 - 9 months ago

  5 - NON-FINAL ACTION E-MAILED Type: GNRT

• 10/23/2024 - 6 months ago

  8 - CORRESPONDENCE RECEIVED IN LAW OFFICE Type: CRFA

• 10/23/2024 - 6 months ago

  9 - TEAS/EMAIL CORRESPONDENCE ENTERED Type: TEME

• 10/23/2024 - 6 months ago

  7 - TEAS RESPONSE TO OFFICE ACTION RECEIVED Type: TROA

• 10/30/2024 - 6 months ago

  10 - EXAMINERS AMENDMENT -WRITTEN Type: CNEA

• 10/30/2024 - 6 months ago

  11 - EXAMINERS AMENDMENT E-MAILED Type: GNEA

• 10/30/2024 - 6 months ago

  13 - EXAMINER'S AMENDMENT ENTERED Type: XAEC

• 10/30/2024 - 6 months ago

  12 - NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED Type: GNEN

• 10/30/2024 - 6 months ago

  14 - APPROVED FOR PUB - PRINCIPAL REGISTER Type: CNSA

• 11/20/2024 - 5 months ago

  15 - NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED Type: NONP

• 11/26/2024 - 5 months ago

  16 - PUBLISHED FOR OPPOSITION Type: PUBO

• 11/26/2024 - 5 months ago

  17 - OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Type: NPUB

• 1/7/2025 - 3 months ago

  18 - NOA E-MAILED - SOU REQUIRED FROM APPLICANT Type: NOAM